BriaCell Therapeutics Corp. (BCTX)

NASDAQ: BCTX · Real-Time Price · USD

3.780

-0.220 (-5.50%)

Feb 27, 2026, 3:01 PM EST - Market open

BriaCell Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Market Capitalization	29	13	14	106	101	79
Market Cap Growth	185.45%	-6.05%	-87.19%	4.90%	29.07%	1427.04%
Enterprise Value	18	-0	12	77	57	59
Last Close Price	4.00	7.46	112.87	1003.50	975.00	762.00
PB Ratio	3.08	0.74	-5.08	-28.18	9.82	2.84
P/TBV Ratio	2.94	0.72	-	-	10.05	2.87
Debt / Equity Ratio	-	-	-	-	-	0.00
Net Debt / Equity Ratio	-1.09	-1.03	0.32	5.63	-3.97	-2.07
Net Debt / EBITDA Ratio	0.34	0.66	0.03	0.91	2.69	8.22
Net Debt / FCF Ratio	0.35	0.63	0.04	0.90	3.29	7.39
Quick Ratio	3.42	4.49	0.21	11.80	43.64	102.88
Current Ratio	3.42	5.01	0.49	14.96	45.00	103.81
Return on Equity (ROE)	-444.07%	-362.56%	-	-619.75%	-141.25%	-114.78%
Return on Assets (ROA)	-161.64%	-123.56%	-126.11%	-41.71%	-18.99%	-14.89%
Return on Capital Employed (ROCE)	-311.30%	-153.90%	2097.70%	-91.80%	-36.70%	-12.10%
Earnings Yield	-99.57%	-205.42%	-35.14%	-19.08%	-26.45%	-17.58%
FCF Yield	-100.31%	-219.93%	-180.31%	-22.31%	-12.30%	-9.86%
Buyback Yield / Dilution	-566.61%	-285.70%	-5.35%	-0.81%	-242.82%	-

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q